Interpretation of the key points of the 2025 AHA/ACC guideline for the prevention, detection, evaluation and management of high blood pressure in adults
- VernacularTitle:《2025 AHA/ACC高血压指南》要点解读
- Author:
Qin SUN
1
;
Aiai LI
1
;
Jing YU
1
;
Dongze LI
1
;
Haihong ZHANG
1
;
Yan ZHONG
2
;
Zhi WAN
1
Author Information
1. Department of Emergency, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
2. Department of Medical Administration, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
Adults;
hypertension;
cardiovascular disease;
risk stratification;
PREVENT model;
individualized therapy;
guidelines;
interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2026;33(02):204-210
- CountryChina
- Language:Chinese
-
Abstract:
The American Heart Association (AHA) and the American College of Cardiology (ACC), in collaboration with multiple professional organizations, jointly released the "Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults" in August 2025. Based on the latest evidence-based medical findings from February 2015 to January 2025, the guideline proposes an individualized treatment strategy grounded in total cardiovascular disease risk stratification, incorporates the novel PREVENT risk assessment model, lowers the medication initiation threshold and control targets for high-risk populations, and provides specific management recommendations for special populations. This article provides an interpretation of these updates and conducts a comparative analysis with the current status of hypertension prevention and treatment in China as well as Chinese guidelines, aiming to offer reference for hypertension control practices in China.
